Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-14

Clinical Trial Update: Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis [NA]

View source ↗

Summary

A planned clinical study to evaluate the efficacy and safety of sequential therapy with efgartigimod and telitacicept in generalized myasthenia gravis; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Efgartigimod (efgartigimod)
  • Telitacicept

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Myasthenia Gravis, Autoimmune Diseases | NA | Status: NOT_YET_RECRUITING